Cadrenal Therapeutics于今日发布了2026年第二季度的财务业绩。与此同时,该公司还就其心脏急性危重症护理业务线,以及正在推进的战略合作伙伴遴选流程,提供了最新情况说明。
Cadrenal Therapeutics于今日发布了2026年第二季度的财务业绩。与此同时,该公司还就其心脏急性危重症护理业务线,以及正在推进的战略合作伙伴遴选流程,提供了最新情况说明。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.